Table 1.
Comparison of clinical data, laboratory results, and other data between the study and control groups
| Study Group (n=80) | Control group (n=40) | t/χ2 | P | |
|---|---|---|---|---|
| Sex | ||||
| Male, n (%) | 43 (53.75) | 21 (52.5) | 0.17 | 0.897 |
| Female, n (%) | 37 (46.25) | 19 (47.5) | ||
| Age (years) | 43.54±11.82 | 43.88±11.79 | –0.148 | 0.883 |
| BMI (kg/m2) | 24.25±3.90 | 24.29±3.47 | –0.056 | 0.956 |
| Total cholesterol level (mmol/L) | 5.08±0.78 | 4.77±0.86 | 2.02 | 0.046 |
| Triglyceride level (mmol/L) | 1.59±0.95 | 1.57±0.88 | 0.079 | 0.937 |
| High-density lipoprotein level (mmol/L) | 1.19±0.25 | 1.49±0.37 | –5.377 | <0.001 |
| Low-density lipoprotein level (mmol/L) | 2.59±0.74 | 2.85±0.75 | –1.765 | 0.08 |
| Adiponectin level (ng/ml) | 28.72±16.69 | 39.50±14.01 | –3.511 | 0.001 |
| Leptin level (ng/ml) | 4.64±2.51 | 1.76±1.34 | 6.774 | <0.001 |
| Carotid IMT value (mm) | 1.02±0.16 | 0.81±0.15 | 6.901 | <0.001 |
| Positive carotid plaque, n (%) | 9 (11.3) | 2 (5) | 1.25 | 0.263 |
| Disease course (months) | 62.20±44.84 | - | ||
| PASI score | 27.24±10.29 | - |
BMI, body mass index; IMT, intimal-medial thickness; PASI, Psoriasis Area and Severity Index